August Bioservices Closes $65M Series B
12/01/22, 1:05 PM
Location
nashvilleMoney raised
$65 million
Industry
pharmaceutical
biotechnology
Round Type
series b
Investors
Polaris Partners
August Bioservices, LLC (“August Bio”), a pharmaceutical contract development and manufacturing organization (CDMO) providing drug discovery, development and pharmaceutical manufacturing services, today announced that it secured $65 million in Series B funding led by Oak HC/FT, who led the Series A in July 2020. This round includes participation from existing investor, Polaris Partners.
Company Info
Location
elm hill pike
nashville, arkansas, united states
Additional Info
August Bioservices is a Contract Development and Manufacturing Organization (CDMO) headquartered in Nashville, Tennessee. August Bio offers a full range of pharmaceutical contract development and manufacturing services to pharmaceutical and biotech clients. We focus on sterile injectables, topicals, highly-complex formulations, poorly soluble & highly viscous compounds, Uncommon container sizes & fill volumes and offer aseptic and non-aseptic terminally sterilized filling of vials (liquid and lyophilized), syringes and flexible IV bags.